1490 related articles for article (PubMed ID: 19810379)
1. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
2. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
4. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
7. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
Jindal N; Arora U; Singh K
Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
[TBL] [Abstract][Full Text] [Related]
10. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
13. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
[TBL] [Abstract][Full Text] [Related]
14. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
16. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica.
Smikle MF; Dowe G; Williams EM; Thesiger C
Hum Antibodies; 2000; 9(4):231-3. PubMed ID: 11341177
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B, hepatitis C and HIV co-infection at an antiretroviral centre in Delhi.
Raizada A; Dwivedi S; Bhattacharya S
Trop Doct; 2011 Jul; 41(3):154-6. PubMed ID: 21586511
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India.
Saha MK; Chakrabarti S; Panda S; Naik TN; Manna B; Chatterjee A; Detels R; Bhattacharya SK
Indian J Med Res; 2000 Feb; 111():37-9. PubMed ID: 10824464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
